Economic Evaluation of Weight Loss Interventions in Overweight and Obese Women

[1]  A. Walker,et al.  Getting a handle on obesity , 2006 .

[2]  J. Gerberding,et al.  Actual causes of death in the United States, 2000. , 2004, JAMA.

[3]  A. Prentice.  Storing up problems: the medical case for a slimmer nation. , 2004, Clinical medicine.

[4]  U. C. Bureau.  Statistical Abstract of the United States , 2004 .

[5]  J. Wechsler,et al.  Medical management of obesity , 2003, Langenbeck's Archives of Surgery.

[6]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[7]  A. Berg,et al.  U.S. Preventive services task force. Behavioral counseling in primary care to promote physical activity: recommendation and rationale. , 2003, The American journal of nursing.

[8]  D. Williamson,et al.  Intentional Weight Loss and Death in Overweight and Obese U.S. Adults 35 Years of Age and Older , 2003, Annals of Internal Medicine.

[9]  D. Allison,et al.  Obesity and quality of life: mediating effects of pain and comorbidities. , 2003, Obesity research.

[10]  Abdullah Al Mamun,et al.  Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis , 2003, Annals of Internal Medicine.

[11]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[12]  U. P. S. T. Force.  Behavioral Counseling in Primary Care To Promote Physical Activity: Recommendation and Rationale , 2002, Annals of Internal Medicine.

[13]  J. Garrett,et al.  The Natural History of the Development of Obesity in a Cohort of Young U.S. Adults between 1981 and 1998 , 2002, Annals of Internal Medicine.

[14]  T. Lancet.  Getting a handle on obesity , 2002, The Lancet.

[15]  Gary D Foster,et al.  Obesity: responding to the global epidemic. , 2002, Journal of consulting and clinical psychology.

[16]  T. Wadden,et al.  Combining behavioral and pharmacological treatments for obesity. , 2002, Obesity research.

[17]  F. McLellan.  Obesity rising to alarming levels around the world , 2002, The Lancet.

[18]  M. Friedrich.  Epidemic of obesity expands its spread to developing countries. , 2002, JAMA.

[19]  T. Wilt,et al.  Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial. , 2002, Archives of internal medicine.

[20]  F Reed Johnson,et al.  Modeling for health care and other policy decisions: uses, roles, and validity. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  G. ter Riet,et al.  The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. , 2002, Health technology assessment.

[22]  R. Wing,et al.  Successful weight loss maintenance. , 2003, Annual review of nutrition.

[23]  James W. Anderson,et al.  Long-term weight-loss maintenance: a meta-analysis of US studies. , 2001, The American journal of clinical nutrition.

[24]  F Vinicor,et al.  The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.

[25]  J D Graham,et al.  Modeling for health care and other policy decisions: uses, roles, and validity. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[26]  G. Côté,et al.  Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey , 2001, BMC women's health.

[27]  G A Colditz,et al.  Impact of overweight on the risk of developing common chronic diseases during a 10-year period. , 2001, Archives of internal medicine.

[28]  S. Phelan,et al.  Weight-loss maintenance in overweight individuals one to five years following successful completion of a commercial weight loss program , 2001, International Journal of Obesity.

[29]  R. N. Anderson,et al.  United States life tables, 1998. , 2001, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[30]  T. Wadden,et al.  Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. , 2001, Archives of internal medicine.

[31]  D. Chapman,et al.  Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. , 2001, Obesity research.

[32]  S. O’Meara,et al.  A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. , 2001, Health technology assessment.

[33]  P. Whiting,et al.  A rapid and systematic review of the clinical effectiveness and cost-effectiveness of debriding agents in treating surgical wounds healing by secondary intention. , 2001, Health technology assessment.

[34]  J. Seidell,et al.  The public health impact of obesity. , 2001, Annual review of public health.

[35]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[36]  A. Drewnowski,et al.  Long-term maintenance of weight loss: current status. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[37]  A. Rissanen,et al.  Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns , 2000, International Journal of Obesity.

[38]  M C Weinstein,et al.  Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[39]  D. Meltzer,et al.  Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus. , 2000, Medical care.

[40]  G. Williams,et al.  One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor , 2000, International Journal of Obesity.

[41]  K. Fontaine,et al.  Health-related quality of life among obese persons seeking and not currently seeking treatment. , 2000, The International journal of eating disorders.

[42]  S. Rössner,et al.  Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. , 2000, Obesity research.

[43]  J. Manson,et al.  A prospective study of weight change and health-related quality of life in women. , 1999, JAMA.

[44]  James W. Anderson,et al.  Long-term weight maintenance after an intensive weight-loss program. , 1999, Journal of the American College of Nutrition.

[45]  R. Wing,et al.  The prevalence of weight loss maintenance among American adults , 1999, International Journal of Obesity.

[46]  G A Colditz,et al.  Economic costs of obesity and inactivity. , 1999, Medicine and science in sports and exercise.

[47]  G. Colditz,et al.  The disease burden associated with overweight and obesity. , 1999, JAMA.

[48]  J M Jakicic,et al.  Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial. , 1999, JAMA.

[49]  G A Colditz,et al.  Lifetime health and economic consequences of obesity. , 1999, Archives of internal medicine.

[50]  M. Thun,et al.  Body-mass index and mortality in a prospective cohort of U.S. adults. , 1999, The New England journal of medicine.

[51]  M. Senekal,et al.  A multidimensional weight-management program for women. , 1999, Journal of the American Dietetic Association.

[52]  G. Oster,et al.  Lifetime health and economic benefits of weight loss among obese persons. , 1999, American journal of public health.

[53]  K. Fujioka,et al.  Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. , 1999, The American journal of clinical nutrition.

[54]  K. Kuntz,et al.  Cost-effectiveness of diagnostic strategies for patients with chest pain. , 1999, Annals of internal medicine.

[55]  D. Lau.  Call for action: preventing and managing the expansive and expensive obesity epidemic. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[56]  T. Wadden,et al.  Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial. , 1999, JAMA.

[57]  S. Heymsfield,et al.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. , 1999, JAMA.

[58]  J. Zavoral.  Treatment with orlistat reduces cardiovascular risk in obese patients , 1998, Journal of hypertension.

[59]  Alain Golay,et al.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients , 1998, The Lancet.

[60]  W L Haskell,et al.  Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. , 1998, The New England journal of medicine.

[61]  P. Freedson,et al.  Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. , 1998, Obesity research.

[62]  T. Wadden,et al.  Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial. , 1998, Journal of consulting and clinical psychology.

[63]  R. Wing,et al.  Lifestyle Intervention in Overweight Individuals With a Family History of Diabetes , 1998, Diabetes Care.

[64]  W. Browner,et al.  Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes. , 1998, JAMA.

[65]  K. Fontaine,et al.  Estimating Health-Related Quality of Life in Obese Individuals , 1998 .

[66]  D. Chisholm,et al.  Obesity: genes, glands or gluttony? , 1998, Reproduction, fertility, and development.

[67]  A. Rissanen,et al.  Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. , 1998, Lancet.

[68]  M. Johannesson,et al.  Incorporating Future Costs in Medical Cost-Effectiveness Analysis , 1997, Medical decision making : an international journal of the Society for Medical Decision Making.

[69]  M. Johannesson,et al.  The cost-effectiveness of a cardiovascular risk reduction program in general practice. , 1997, Health policy.

[70]  S. Rabkin,et al.  Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[71]  J. Després,et al.  Obesity in Canada: a descriptive analysis. Canadian Heart Health Surveys Research Group. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[72]  J. Feldman,et al.  Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. , 1997, BMJ.

[73]  S. Pauker,et al.  Patient-specific decisions about hormone replacement therapy in postmenopausal women. , 1997, JAMA.

[74]  T. Wadden,et al.  Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood. , 1997, Journal of consulting and clinical psychology.

[75]  B. Levine,et al.  Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive? , 1997, The American journal of cardiology.

[76]  M. Evans,et al.  Body weight and mortality among women. , 1997, Canadian family physician Medecin de famille canadien.

[77]  David O. Meltzer,et al.  Accounting for future costs in medical cost-effectiveness analysis. , 1997 .

[78]  R. Nease,et al.  The importance of patient preferences for comorbidities in cost-effectiveness analyses. , 1997, Journal of health economics.

[79]  D. Meltzer,et al.  Accounting for Future Costs in Medical Cost-Effectiveness Analysis , 1997, Journal of health economics.

[80]  M. Weinstein,et al.  Theoretical issues in cost-effectiveness analysis. , 1997, Journal of health economics.

[81]  J. Després,et al.  Obesity in Canada: a descriptive analysis. Canadian Heart Health Surveys Research Group. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[82]  S. Rabkin,et al.  Risk factor correlates of body mass index , 1997 .

[83]  T. Sheldon,et al.  The treatment and prevention of obesity: a systematic review of the literature. , 1997, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[84]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[85]  D. Williamson,et al.  The 25-year health care costs of women who remain overweight after 40 years of age. , 1996, American journal of preventive medicine.

[86]  A. Gotto,et al.  Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. , 1996, Journal of the American Dietetic Association.

[87]  G. Butterfield,et al.  Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women. , 1996, The American journal of clinical nutrition.

[88]  I. Sartori.  Weight, Weight Change, and Coronary Heart Disease in Women: Risk Within the 'Normal' Weight Range , 1996 .

[89]  A. Sowden,et al.  Bulletin on the effectiveness of health service interventions for decision makers , 2022 .

[90]  T. Wadden,et al.  Relation of weight loss to changes in serum lipids and lipoproteins in obese women. , 1995, The American journal of clinical nutrition.

[91]  P. Ewbank,et al.  Physical activity as a predictor of weight maintenance in previously obese subjects. , 1995, Obesity research.

[92]  J. Manson,et al.  Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. , 1995, JAMA.

[93]  R. Wing,et al.  Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[94]  P. Blackman.  Actual causes of death in the United States. , 1994, JAMA.

[95]  Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.

[96]  McGinnis Jm,et al.  Actual causes of death in the United States. , 1993 .

[97]  Pi-Sunyer Fx.  Short-Term Medical Benefits and Adverse Effects of Weight Loss , 1993 .

[98]  F. Pi‐Sunyer,et al.  Medical Hazards of Obesity , 1993, Annals of Internal Medicine.

[99]  C. Christiansen,et al.  Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. , 1993, The American journal of medicine.

[100]  R. Klein,et al.  The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[101]  Goldstein Dj.  Beneficial health effects of modest weight loss , 1992 .

[102]  B. Goldstein,et al.  Beneficial health effects of modest weight loss. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[103]  D. Safer.  Diet, Behavior Modification, and Exercise: A Review of Obesity Treatments from a Long‐Term Perspective , 1991, Southern medical journal.

[104]  W. Haskell,et al.  The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. , 1991, The New England journal of medicine.

[105]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[106]  G A Colditz,et al.  Weight as a risk factor for clinical diabetes in women. , 1990, American journal of epidemiology.

[107]  M. Weinstein,et al.  A cost-effectiveness analysis of exercise as a health promotion activity. , 1988, American journal of public health.

[108]  M S Kramer,et al.  Methodologic standards for controlled clinical trials of early contact and maternal-infant behavior. , 1984, Pediatrics.

[109]  G. O. Lignac.  [Actual causes of death]. , 1951, Nederlands tijdschrift voor geneeskunde.